Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers.
T cells from ART-suppressed individuals can originate from biologically competent proviruses.
Caffeine, a Risk Factor for Osteoarthritis and Longitudinal Bone Growth Inhibition.
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals.
Improving HIV Outgrowth by Optimizing Cell-Culture Conditions and Supplementing With all-trans Retinoic Acid
Dynamics of the decay of HIV RNA and distribution of bictegravir in the genital tract and rectum in antiretroviral-naïve HIV-1-infected adults treated with bictegravir/emtricitabine/tenofovir alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58).
Are We Ready for NGS HIV Drug Resistance Testing? The Second "Winnipeg Consensus" Symposium.
Purification of Recombinant Galectins Expressed in Bacteria.
Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.